Codes / ICD10CM / M1A.2210

M1A.2210 Drug-induced chronic gout, right elbow, without tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug-Induced Chronic Gout, Right Elbow, Without Tophus (Tophi)

Summary

Drug-induced chronic gout, right elbow, without tophus is a form of arthritis affecting the right elbow joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms without the presence of tophi (urate crystal deposits) in this stage.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the right elbow joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

  • Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
  • Prolonged exposure to urate-raising drugs
  • Pre-existing hyperuricemia or gout history
  • Renal impairment affecting drug clearance

Symptoms

  • Recurrent episodes of intense right elbow pain, often with swelling and redness
  • Persistent warmth and tenderness in the affected elbow
  • Stiffness and limited range of motion in the elbow
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis may identify urate crystals. Imaging, such as X-rays or ultrasound, assesses joint damage and rules out other conditions. The absence of tophi is confirmed clinically or via imaging.

Treatment Options

Treatment focuses on managing uric acid levels and reducing inflammation. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatory drugs (e.g., NSAIDs or colchicine). Lifestyle modifications, such as dietary changes, may also be recommended. In some cases, discontinuing the causative drug is necessary.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is essential to monitor uric acid levels and adjust treatment. Untreated or poorly managed cases may progress to chronic joint damage or the formation of tophi.

Complications

  • Chronic joint damage or deformity in the right elbow
  • Recurrent flare-ups leading to functional impairment
  • Potential progression to tophaceous gout if uric acid levels remain uncontrolled

Lifestyle & Prevention

  • Avoid medications known to elevate uric acid levels when possible
  • Maintain a balanced diet low in purines (e.g., limit red meat, seafood)
  • Stay hydrated to support uric acid excretion
  • Follow prescribed treatment plans consistently

When to Seek Professional Help

Seek medical attention if you experience severe or persistent right elbow pain, swelling, or stiffness, or if symptoms worsen despite treatment. Prompt evaluation is important to prevent long-term joint damage.

Tips for Medical Coders

This code specifies drug-induced chronic gout affecting the right elbow without tophi. Document the affected joint (right elbow) and the absence of tophi clearly. Ensure the underlying drug-induced cause is supported by clinical documentation. Use this code only when tophi are not present; if tophi develop, coding should reflect that change.

Book a walkthrough

M1A.2210 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.